Latest Insights

EU: Falsified Medicines Directive: Implications for parallel importers and of Brexit

EU: Falsified Medicines Directive: Implications for parallel importers and of Brexit This article was updated: 8 October 2018 Introduction to the Falsified Medicines Directive Directive 2011/62/EU, better known as “The Falsified Medicines Directive” or “FMD”, came into force on 2 January 2013, with the aim of preventing falsified medicines from entering the legitimate supply chain… Read more »

WIPO Magazine has announced the launch of a new tool linking patents and drugs: Pat-INFORMED

WIPO Magazine has announced[1] the launch of a new tool linking patents and drugs: Pat-INFORMED The concept The World Intellectual Property Organization (WIPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), together with 20 participating global pharmaceutical companies, have joined forces to globalise the concept of the US’s ‘Orange Book’. Most drugs have… Read more »

“It’s immoral!” – Pitfalls of failing to register your trademarks; increased risks in China

“It’s immoral!” – Pitfalls of failing to register your trademarks; increased risks in China. Background: For a number of reasons, it is generally recognised as best practice is to secure a trade mark registration for your brands. Despite your best endeavours, however, trade mark applications can be rejected on a range of different grounds, including… Read more »

Brexit: Considerations for European Union Trade Marks and Registered Community Designs

Brexit: Considerations for European Union Trade Marks and Registered Community Designs What is the current situation? The UK is to leave the EU (“Brexit”) on 29 March 2019. When Brexit becomes fully effective, EU unitary trade mark registrations (“EUTMs”) and registered Community designs (“RCDs”) will cease to have effect in the UK, but will continue… Read more »

Preparations for AI patenting in Europe

Preparations for AI patenting in Europe Patent Partner, Mike Jennings recently wrote a short article on Artificial Intelligence Patenting in Europe for Bio Science today magazine which discusses briefly the timelines of the patenting process and how current legislation has and will continue to change to keep up with the fast technological developments in the industry…. Read more »

UK and the UPC: What Will Happen Post-Brexit?

UK and the UPC: What Will Happen Post-Brexit? Partner and Solicitor Geoff Hussey, and  Patent Attorney Nick South write for Lawyer Monthly on behalf of the Charted Institute of Patent Attorneys on Brexit, and what is likely to happen over the next 9 months.  This article was published originally by Lawyer Monthly  on 29 June… Read more »

Assessment of “plausibility” requirement from the EPO perspective

Assessment of “plausibility” requirement from the EPO perspective Introduction This article considers how the EPO views the requirement of “plausibility”, which can arise during both the assessment of “sufficient disclosure” of the invention and “inventive step” in proceedings before the EPO, particularly in relation to inventions in the Pharmaceuticals and Life Sciences field. The EPO… Read more »

Transliterations

Transliterations When filing your trade marks overseas, it is prudent to consider whether it is necessary to file translations and/or transliterations into the local language/script. A trade mark registration in one language will not automatically give you the right to prevent third parties from adopting a translation or a transliteration of your mark. As Trade… Read more »

Anti-counterfeiting 2018 – A Global Guide

Anti-counterfeiting 2018 – A Global Guide Trade Mark Associate Louise Foster and Litigation Associate Dr. Varuni Paranavitane recently wrote the UK section of the ‘Anti-Counterfeiting 2018 – A Global Guide’. You can read the UK section below, or find the full guide and other articles published by the World Trade Mark Review here: www.WorldTrademarkReview.com.  This… Read more »

Categories

Archives